Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jan 15;139(3):376-379.
doi: 10.1161/CIRCULATIONAHA.118.038677.

Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss

Sankar D Navaneethan  1   2
Affiliations
Editorial

Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss

Sankar D Navaneethan. Circulation. .
No abstract available

Keywords: Editorials; kidney diseases; obesity; weight loss.

PubMed Disclaimer

Comment on

  • Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.
    Scirica BM, Bohula EA, Dwyer JP, Qamar A, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Murphy SA, Im K, Leiter LA, Gupta M, Patel T, Miao W, Perdomo C, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD; CAMELLIA-TIMI 61 Steering Committee and Investigators. Scirica BM, et al. Circulation. 2019 Jan 15;139(3):366-375. doi: 10.1161/CIRCULATIONAHA.118.038341. Circulation. 2019. PMID: 30586726 Clinical Trial.

References

    1. Whaley-Connell A, Sowers JR. Obesity and kidney disease: from population to basic science and the search for new therapeutic targets. Kidney Int. 2017; 92: 313–323. - PubMed
    1. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006; 144: 21–28. - PubMed
    1. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008; 73: 19–33. - PubMed
    1. Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, Bays H, Shanahan WR, Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010; 363: 245–256. - PubMed
    1. Scirica BM, Bohula EA, Dwyer JP, Qamar A, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Murphy SA, Im K, Leiter LA, Gupta M, Patel T, Miao W, Perdamo C, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD for the CAMELLIA-TIMI 61 Steering Committee and Investigators.. Lorcaserin and renal outcomes in obese and overweight patients in the CAMELLIA-TIMI 61 trial. Circulation. 2018; 10.1161/CIRCULATIONAHA.118.038341 [In Press]. - DOI - PubMed